فهرست:
فصل اول- مقدمه و بیان مسأله. 1
1-1 مقدمه 2
1-٢ بیان مسأله و اهمیت پژوهش.. 2
1-3 اهداف و فرضیات. 8
1-3-1 اهداف اصلی. 8
1-3-3 سوالات پژوهش.. 9
1-3-4 فرضیات پژوهش.. 9
فصل دوم - بررسی متون: 11
٢-1 مقدمه 12
٢-٢ مبانی نظری پژوهش.. 12
٢-3 مروری بر مطالعات انجام شده 12
٢-3-1 مروری بر مطالعات انجام شده در ایران: 12
2-3-2 مروری بر مطالعات انجام شده در جهان: 15
فصل سوم - روش پژوهش: 23
3-1 مقدمه 24
3-2 نوع پژوهش.. 25
3-3 جامعه پژوهش : همراه با معیار ورود و خروج. 26
3-4 روش نمونه گیری و حجم نمونه: مشخصات نمونه‌های مورد بررسی (معیار ورود و خروج) همراه با روش نمونه گیری و حجم نمونه 27
تعیین حجم نمونه و نحوه محاسبه آن (Sample Size) : 27
3-5 روش گرداوری داده‌ها و اجرای تحقیق. 28
3-6 ابزار گرداوری داده ها 30
3-7 روش تجزیه و تحلیل داده ها 32
3-8 مکان و زمان مطالعه 33
3-9 محدودیت پژوهش.. 33
3-10 ملاحظات اخلاقی. 34
3-10 تعریف واژه ها 34
فصل چهارم - یافته ها: 37
فصل پنجم - بحث، نتیجه گیری و ارائه پیشنهادات: 45
قسمت بحث: 46
اثر پروبیوتیک بر قند خون ناشتا 46
اثر پروبیوتیک بر پروفایل لیپیدی: 49
اثر پروبیوتیک بر انسولین. 51
نقش پروبیوتیک‌ها در مقاومت انسولینی (IR) 52
اثر پروبیوتیک بر وزن بدن و دریافت غذایی. 53
قسمت نتیجه گیری: 56
قسمت پیشنهادات: 57
منابع: 59
پیوست ها 67
پیوست شماره 1 : 67
نمونه برگه رضایت نامه 67
پیوست شماره 2 : 69
نمونه برگه اطلاع رسانی. 69
مقدمه ای مختصر و به زبان ساده با اصلاحات فارسی قابل فهم برای تمام آزمودنی‌ها در مورد موضوع و هدف پژوهش: 69
پیوست شماره 3 : 71
پیوست شماره 4: 72
نمونه یادآمد 24 ساعته خوراک.. 72
پیوست شماره 5: 73
پرسشنامه ارزیابی میزان فعالیت بدنی. 73
Abstract: 74
منبع:
Al-Salami, H., G. Butt, J. P. Fawcett, I. G. Tucker, S. Golocorbin-Kon and M. Mikov (2012). "Probiotic treatment reduces blood glucose leveis and increases systemic absorption of gliclazide in diabetic rats." European Journal of Drug Metabolism and Pharmacokinetics 33(2): 101-106.
Al-Salami, H., G. Butt, I. Tucker, S. Golocorbin-Kon and M. Mikov (2012). "Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats." European Journal of Drug Metabolism and Pharmacokinetics 37(2): 99-108.
Andersson, U., C. Branning, S. Ahrne, G. Molin, J. Alenfall, G. Onning, et al. (2010). "Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse." Benef Microbes 1(2): 189-196.
Andreasen, A. S., N. Larsen, T. Pedersen-Skovsgaard, R. M. Berg, K. Moller, K. D. Svendsen, et al. (2010). "Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects." Br J Nutr 104(12): 1831-1838.
Andresean, V. and D. C. Baumgart (2007). " Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence." international journal of probiotics and prebiotics 1: 8.
Asemi, Z., A. Khorrami-Rad, S. A. Alizadeh, H. Shakeri and A. Esmaillzadeh (2014). "Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial." Clin Nutr 33(2): 198-203.
Asemi, Z., M. Samimi, Z. Tabassi, M. Naghibi Rad, A. Rahimi Foroushani, H. Khorammian, et al. (2013). "Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: A randomized controlled trial." European Journal of Clinical Nutrition 67(1): 71-74.
Asemi, Z., Z. Zare, H. Shakeri, S. S. Sabihi and A. Esmaillzadeh (2013). "Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes." Ann Nutr Metab 63(1-2): 1-9.
Ashar, M. N. and J. B. Prajapati (2000). "Verification of hypocholesterolemic effect of fermented milk on human subjects with different cholesterol levels." Folia Microbiol (Praha) 45(3): 263-268.
Association, A. D. (2014). "Standards of Medical Care in Diabetes—2014." Diabetes Care 37(Supplement 1): S14-S80.
Azizi, F., H. Hatami and M. Janghorbani (2007). "Epidemiology and control of common diseases in Iran." 4.
Bee and Peta. (November 2008). "Probiotics, Not so friendly after all" http://www.timesonline.co.uk/tol/life_and_style/health/features/article5109777.ece." The Times (London), from http://www.timesonline.co.uk/tol/life_and_style/health/features/article5109777.ece.
Bejar, W., K. Hamden, R. Ben Salah and H. Chouayekh (2013). "Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats." Anaerobe 24: 4-11.
Besselink MG, v. S. H., Buskens E (February 2008). "Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial"." Lancet 371 9613: 8.
Calcinaro, F., S. Dionisi, M. Marinaro, P. Candeloro, V. Bonato, S. Marzotti, et al. (2005). "Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse." Diabetologia 48(8): 1565-1575.
Chen, P., Q. Zhang, H. Dang, X. Liu, F. Tian, J. Zhao, et al. (2014). "Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin." Nutrition 30(9): 1061-1068.
Chiu, C. Lu, Y. Y. Tseng ,T. M. Pan (2006). "The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet." Appl Microbiol Biotechnol 71(2): 238-245.
Choi, H. J., J. Yu, H. Choi, J. H. An, S. W. Kim, K. S. Park, et al. (2011). "Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial." Diabetes Care 34(9): e147.
Daily Mail, from http://www.dailymail.co.uk/health/article-510978/So-called-friendly-bacteria-dangerous-according-new-research--taking.html
Dalla Vestra, M., M. Mussap, P. Gallina, M. Bruseghin, A. M. Cernigoi, A. Saller, et al. (2005). "Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes." J Am Soc Nephrol 16 Suppl 1: S78-82.
Davari, S., S. A. Talaei, H. Alaei and M. Salami (2013). "Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis." Neuroscience 240: 287-296.
Davari, S., S. A. Talaei, M. Salami, M. R. Fazeli and H. Alaei (2013). "Effects of supplementation with probiotics on long-term potentiation impairment in diabetic rats." Journal of Isfahan Medical School 30(218): 2236-2247.
Davari, S., S. A. Talaei, M. Soltani, H. Alaei and M. Salami (2012). "The effect of co-administration of lactobacillus probiotics and bifidobacterium on spatial memory and learning in diabetic rats." Tehran University Medical Journal 70(9): 531-539.
Ejtahed, H. S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi , V. Mofid (2012). "Probiotic yogurt improves antioxidant status in type 2 diabetic patients." Nutrition 28(5): 539-543.
Ejtahed, H. S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, V. Mofid, et al. (2011). "Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus." Journal of Dairy Science 94(7): 3288-3294.
Ejtahed, H. S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, V. Mofid, et al. (2011). "Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus." J Dairy Sci 94(7): 3288-3294.
Ejtahed, H. S., J. Mohtadi Nia, A. Homayouni Rad, M. Niafar, M. Asghari Jafarabadi and V. Mofid (2011). "The effects of probiotic and conventional yoghurt on diabetes markers and insulin resistance in type 2 diabetic patients: A randomized controlled clinical trial." Iranian Journal of Endocrinology and Metabolism 13(1): 112.
FAO/WHO (2001). "Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria."
FDA Food and Drug Administration: http://www.fda.gov/downloads/food/ingredientspackaginglabeling/gras/noticeinventory/ucm309143.pdf." from http://www.fda.gov/downloads/food/ingredientspackaginglabeling/gras/noticeinventory/ucm309143.pdf
François-Joseph, F. (2011). "Biographie Universelle des Musiciens et Bibliographie Générale de la Musique، Tome 1 (Second ed.). Paris: Firmin Didot Frères، Fils، et Cie.": 5.
Gilliland, S. E. and D. K. Walker (1990). "Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans." J Dairy Sci 73(4): 905-911.
Grover, S., H. M. Rashmi, A. K. Srivastava and V. K. Batish (2012). "Probiotics for human health -new innovations and emerging trends." Gut Pathog 4(1): 15.
Ham, J. S., S. G. Jeong, Y. B. Noh, J. H. Shin, G. S. Han, H. S. Chae, et al. (2007). "Effect of milk containing streptococcus thermophilus KACC 91147 on blood glucose levels." Korean Journal for Food Science of Animal Resources 27(4): 496-500.
Honda, K., M. Moto, N. Uchida, F. He and N. Hashizume (2012). "Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice." J Clin Biochem Nutr 51(2): 96-101.
Hove, K., C. Brons, K. Faerch, S. S. Lund, P. Rossing and A. Vaag (2014). "Effects of 12 weeks treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study." Eur J Endocrinol.
Hsieh, F. C., C. L. Lee, C. Y. Chai, W. T. Chen, Y. C. Lu and C. S. Wu (2013). "Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats." Nutr Metab (Lond) 10(1): 35.
Huang, H. Y., M. Korivi, C. H. Tsai, J. H. Yang and Y. C. Tsai (2013). "Supplementation of Lactobacillus plantarum K68 and Fruit-Vegetable Ferment along with High Fat-Fructose Diet Attenuates Metabolic Syndrome in Rats with Insulin Resistance." Evid Based Complement Alternat Med 2013: 943020.
IDF. (2012). "International Diabetes Federation: About Diabetes", http://www.idf.org/about-diabetes." from http://www.idf.org/about-diabetes.
IDF. (2013). "International Diabetes Federation (IDF) : Diabetes in Iran." from http://www.idf.org/membership/mena/iran.
Jadad, A. R., R. A. Moore, D. Carroll, C. Jenkinson, D. J. Reynolds, D. J. Gavaghan, et al. (1996). "Assessing the quality of reports of randomized clinical trials: is blinding necessary?" Control Clin Trials 17(1): 1-12.
January 2008). "So-called 'friendly' bacteria may be dangerous, according to new research - so which should you be taking?" http://www.dailymail.co.uk/health/article-510978/So-called-friendly-bacteria-dangerous-according-new-research--taking.html
Kim, S. T. Kim, K. H. Lee, Y. R. Choi, H. J. Kim, I. S. Shin, et al. (2012). "Steam-dried ginseng berry fermented with Lactobacillus plantarum controls the increase of blood glucose and body weight in type 2 obese diabetic db/db mice." Journal of Agricultural and Food Chemistry 60(21, 544-5438-.
King, H., R. E. Aubert and W. H. Herman (1998). "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections." Diabetes Care 21(9): 1414-1431.
Lin, C. H., C. C. Lin, M. A. Shibu, C. S. Liu, C. H. Kuo, F. J. Tsai, et al. (2013). "Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus." Br J Nutr: 1-8.
Lin, C. H. Lin, M. A. Shibu, C. S. Liu, C. H. Kuo, F. J. Tsai, et al. (2014). "Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus." Br J Nutr 111(4): 598-605.
Lu, Y. C., L. T. Yin, W. T. Chang and J. S. Huang (2010). "Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats." Journal of Bioscience and Bioengineering 110(6): 709-715.
Mahan, L. k., S. S. Stump and J. Reymond (2012). Krause's food and nutriton care process, chapter 31, Medical Nutrition Therapy for Diabetes Mellitus and Hypoglycemia of Nondiabetic Origin.
Maioli, M., G. M. Pes, M. Sanna, S. Cherchi, M. Dettori, E. Manca, et al. (2008). "Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance." Acta Diabetol 45(2): 91-96.
Manirarora, J. N., S. A. Parnell, Y. H. Hu, M. M. Kosiewicz and P. Alard (2011). "NOD dendritic cells stimulated with Lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidence." Clin Dev Immunol 2011: 630187.
Marazza, J. A., J. G. LeBlanc, G. S. de Giori and M. S. Garro (2013). "Soymilk fermented with Lactobacillus rhamnosus CRL981 ameliorates hyperglycemia, lipid profiles and increases antioxidant enzyme activities in diabetic mice." Journal of Functional Foods.
Mathers, J. C., F. Fernandez, M. J. Hill, P. T. McCarthy, M. J. Shearer and A. Oxley (1990). "Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats." Br J Nutr 63(3): 639-652.
Matsuzaki, T., Y. Nagata, S. Kado, K. Uchida, S. Hashimoto and T. Yokokura (1997). "Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice." APMIS 105(8): 637-642.
Matsuzaki, T., Y. Nagata, S. Kado, K. Uchida, I. Kato, S. Hashimoto, et al. (1997). "Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei." APMIS 105(8): 643-649.
Matsuzaki, T., R. Yamazaki, S. Hashimoto and T. Yokokura (1997). "Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice." Endocrine Journal 44(3): 357-365.
Mazloom, Z., A. Yousefinejad and M. H. Dabaghmanaesh (2013). "Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial." Iranian Journal of Medical Sciences 38(1): 38-43.
Mohamadshahi, M., M. Veissi, F. Haidari, H. Shahbazian, G. A. Kaydani and F. Mohammadi (2014). "Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes." Bioimpacts 4(2): 83-88.
Moroti, C., L. F. Souza Magri, M. de Rezende Costa, D. C. Cavallini and K. Sivieri (2012). "Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus." Lipids Health Dis 11: 29.
Rachmilewitz، and D (2009). "Toll-like receptor signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis." Gastroenterology 520: 402.
Rijkers, G. T., W. M. de Vos, R.-J. Brummer, L. Morelli, G. Corthier and P. Marteau (2011). "Health benefits and health claims of probiotics: bridging science and marketing." British Journal of Nutrition 106(09): 1291-1296.
Roberfroid, M. B. (2000). "Prebiotics and probiotics: are they functional foods?" Am J Clin Nutr 71(6 Suppl): 1682S-1687S; discussion 1688S-1690S.
Roselino, M. N., N. D. Pauly-Silveira, D. C. Cavallini, L. S. Celiberto, R. A. Pinto, R. C. Vendramini, et al. (2012). "A potential synbiotic product improves the lipid profile of diabetic rats." Lipids Health Dis 11: 114.
Schlundt and Jorgen. (Retrieved 17 December 2012.). "Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria." FAO / WHO, from http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
Skeptical Comment About Double-Blind Trials (2010)." The Journal of Alternative and Complementary Medicine 16(4): 339-339
Smedman, A. E., I.-B. Gustafsson, L. G. Berglund and B. O. Vessby (1999). "Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors." The American Journal of Clinical Nutrition 69(1): 22-29.
Tabuchi, M., M. Ozaki, A. Tamura, N. Yamada, T. Ishida, M. Hosoda, et al. (2003). "Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats." Biosci Biotechnol Biochem 67(6): 1421-1424.
Tanida, M., K. Imanishi, H. Akashi, Y. Kurata, O. Chonan, E. Naito, et al. (2014). "Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats." J Diabetes Investig 5(2): 153-161.
Tomaro-Duchesneau, C., S. Saha, M. Malhotra, M. L. Jones, A. Labbe, L. Rodes, et al. (2014). "Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats." Appl Microbiol Biotechnol 98(1): 115-126.
UnderAcademy. (2012). "Types of research methods : http://www.underacademy.org/distinguishing-between-the-types-of-research-papers-and-their-components." from http://www.underacademy.org/distinguishing-between-the-types-of-research-papers-and-their-components.
U.S. Food and Drug Administration (FDA), USA: National Archives and Records Administration’s Electronic. Code of Federal Regulations. Inc; c2002 [cited 2002, Oct 22]; [21CFR184.1440]." from http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=184.1440WHO. (2011). "World Health Organization (WHO) , "Diabetes Action now , in developed and developing countries"." from http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf.
WHO (World Health Organization) : Diabetes, http://www.who.int/topics/diabetes_mellitus/en/." from http://www.who.int/topics/diabetes_mellitus/en/
Yadav, H., S. Jain and P. R. Sinha (2006). "Effect of skim milk and dahi (yogurt) on blood glucose, insulin, and lipid profile in rats fed with high fructose diet." J Med Food 9(3): 328-335.
Yadav, H., S. Jain and P. R. Sinha (2007). "Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats." Nutrition 23(1): 62-68.
Yadav, H., S. Jain and P. R. Sinha (2008). "Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats." J Dairy Res 75(2): 189-195.
Yoshida, M., P. F. Jacques, J. B. Meigs, E. Saltzman, M. K. Shea, C. Gundberg, et al. (2008). "Effect of vitamin K supplementation on insulin resistance in older men and women." Diabetes Care 31(11): 2092-2096.
Yun, S. I., H. O. Park and J. H. Kang (2009). "Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes." J Appl Microbiol 107(5): 1681-1686.
Zarfeshani, A., H. Khaza'ai, R. Mohd Ali, Z. Hambali, K. W. J. Wahle and M. S. A. Mutalib (2011). "Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats." Probiotics and Antimicrobial Proteins 3(3-4): 168-174.
Zhang, Y., X. Guo, J. Guo, Q. He, H. Li, Y. Song, et al. (2014). "Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx." Sci Rep 4: 5654.
Zhang, Y., L. Wang, J. Zhang, Y. Li, Q. He, H. Li, et al. (2013). "Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats." Eur J Nutr.
Zhang, Y., L. Wang, J. Zhang, Y. Li, Q. He, H. Li, et al. (2014). "Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats." Eur J Nutr 53(1): 221-232.